Literature DB >> 15574742

N-cadherin juxtamembrane domain modulates voltage-gated Ca2+ current via RhoA GTPase and Rho-associated kinase.

Giuseppe Piccoli1, Urs Rutishauser, Juan L Brusés.   

Abstract

The juxtamembrane domain (JMD) of N-cadherin cytoplasmic tail is an important regulatory region of the clustering and adhesion activities of the protein. In addition, the JMD binds a diversity of proteins capable of modifying intracellular processes including cytoskeletal rearrangement mediated by Rho GTPases. These GTPases also function as regulators of voltage-activated calcium channels, which in turn modulate neuronal excitability. The present study was designed to determine whether there is a direct functional link, via Rho GTPase, between the N-cadherin JMD and these voltage-activated channels. It was found that the infusion of the soluble JMD into chick ciliary neurons causes a substantial decrease in the amplitude of the high-threshold voltage-activated (HVA) calcium current. The activation time is increased while the inactivation process is reduced, suggesting that the decreased current amplitude reflects a reduction in the number of channels available to open. This effect was reversed by inhibition of RhoA or its downstream effector, Rho-associated kinase (ROCK). Because ROCK determines the active state of myosin, these results suggest that the modulation of HVA by the JMD could be mediated by changes in the status of the actin-myosin cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15574742      PMCID: PMC6730207          DOI: 10.1523/JNEUROSCI.4020-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  9 in total

1.  Synchronous and asynchronous transmitter release at nicotinic synapses are differentially regulated by postsynaptic PSD-95 proteins.

Authors:  Robert A Neff; William G Conroy; Jeffrey D Schoellerman; Darwin K Berg
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

2.  RhoA GTPase and F-actin dynamically regulate the permeability of Cx43-made channels in rat cardiac myocytes.

Authors:  Mickaël Derangeon; Nicolas Bourmeyster; Isabelle Plaisance; Caroline Pinet-Charvet; Qian Chen; Fabien Duthe; Michel R Popoff; Denis Sarrouilhe; Jean-Claude Hervé
Journal:  J Biol Chem       Date:  2008-07-29       Impact factor: 5.157

3.  N-cadherin modulates voltage activated calcium influx via RhoA, p120-catenin, and myosin-actin interaction.

Authors:  Glen S Marrs; Christopher S Theisen; Juan L Brusés
Journal:  Mol Cell Neurosci       Date:  2008-12-31       Impact factor: 4.314

Review 4.  N-cadherin signaling in synapse formation and neuronal physiology.

Authors:  Juan L Brusés
Journal:  Mol Neurobiol       Date:  2006-06       Impact factor: 5.682

Review 5.  Cell adhesion and intracellular calcium signaling in neurons.

Authors:  Lifu Sheng; Iryna Leshchyns'ka; Vladimir Sytnyk
Journal:  Cell Commun Signal       Date:  2013-12-13       Impact factor: 5.712

6.  Generation and transplantation of reprogrammed human neurons in the brain using 3D microtopographic scaffolds.

Authors:  Aaron L Carlson; Neal K Bennett; Nicola L Francis; Apoorva Halikere; Stephen Clarke; Jennifer C Moore; Ronald P Hart; Kenneth Paradiso; Marius Wernig; Joachim Kohn; Zhiping P Pang; Prabhas V Moghe
Journal:  Nat Commun       Date:  2016-03-17       Impact factor: 14.919

7.  Lysophosphatidic Acid and Several Neurotransmitters Converge on Rho-Kinase 2 Signaling to Manage Motoneuron Excitability.

Authors:  Victoria García-Morales; Ángela Gento-Caro; Federico Portillo; Fernando Montero; David González-Forero; Bernardo Moreno-López
Journal:  Front Mol Neurosci       Date:  2021-12-06       Impact factor: 5.639

8.  N-cadherin induces partial differentiation of cholinergic presynaptic terminals in heterologous cultures of brainstem neurons and CHO cells.

Authors:  Richard J Flannery; Juan L Brusés
Journal:  Front Synaptic Neurosci       Date:  2012-12-05

9.  Pharmacology of cell adhesion molecules of the nervous system.

Authors:  Darya Kiryushko; Elisabeth Bock; Vladimir Berezin
Journal:  Curr Neuropharmacol       Date:  2007-12       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.